David J Taber

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. ncbi request reprint The concept of a composite perioperative quality index in kidney transplantation
    David J Taber
    Medical University of South Carolina, Division of Transplant Surgery, Charleston, SC Electronic address
    J Am Coll Surg 218:588-97. 2014
  2. doi request reprint Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    Clin Transplant 27:274-82. 2013
  3. doi request reprint The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    J Cardiovasc Pharmacol Ther 18:243-50. 2013
  4. doi request reprint Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients
    David J Taber
    Medical University of South Carolina, Charleston, SC 29425, USA
    Am J Med Qual 28:103-12. 2013
  5. ncbi request reprint The impact of diabetes on ethnic disparities seen in kidney transplantation
    David J Taber
    Medical University of South Carolina, Division of Transplant Surgery, 96 Jonathan Lucas Street, CSB 409, Charleston, SC 29466, USA
    Ethn Dis 23:238-44. 2013
  6. doi request reprint Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    Pharmacotherapy 32:1053-60. 2012
  7. ncbi request reprint Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients
    David J Taber
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC 29425, USA
    Ann Pharmacother 41:944-50. 2007
  8. doi request reprint No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies
    David J Taber
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC 29425, USA
    Surg Laparosc Endosc Percutan Tech 19:153-6. 2009
  9. doi request reprint Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation
    D J Taber
    Medical University of South Carolina, Department of Pharmacy Services, Charleston, South Carolina 29425, USA
    Transplant Proc 40:3401-7. 2008
  10. doi request reprint Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation
    Emily B Hammond
    College of Medicine, Medical University of South Carolina, Charleston, SC, USA
    Clin Transplant 24:40-7. 2010

Collaborators

Detail Information

Publications31

  1. ncbi request reprint The concept of a composite perioperative quality index in kidney transplantation
    David J Taber
    Medical University of South Carolina, Division of Transplant Surgery, Charleston, SC Electronic address
    J Am Coll Surg 218:588-97. 2014
    ..Therefore, the aim of this study was to determine the association between a kidney transplantation centers' perioperative quality benchmarking and graft and patient outcomes...
  2. doi request reprint Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    Clin Transplant 27:274-82. 2013
    ....
  3. doi request reprint The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    J Cardiovasc Pharmacol Ther 18:243-50. 2013
    ..483). CVD is common in transplant recipients, with black patients having higher rates and poorer control of diabetes and dyslipidemia...
  4. doi request reprint Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients
    David J Taber
    Medical University of South Carolina, Charleston, SC 29425, USA
    Am J Med Qual 28:103-12. 2013
    ..In conclusion, a multidisciplinary quality improvement initiative can improve medication safety in kidney transplant patients, which can lead to improved clinical outcomes...
  5. ncbi request reprint The impact of diabetes on ethnic disparities seen in kidney transplantation
    David J Taber
    Medical University of South Carolina, Division of Transplant Surgery, 96 Jonathan Lucas Street, CSB 409, Charleston, SC 29466, USA
    Ethn Dis 23:238-44. 2013
    ..In conclusion, AA ethnicity continues to be an important risk factor for graft loss, which can be significantly attenuated by controlling for pre-existing diabetes, glycemic control, and other transplant and cardiovascular variables...
  6. doi request reprint Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    Pharmacotherapy 32:1053-60. 2012
    ..To determine the incidence, risk factors, and clinical outcomes associated with clinically significant medication errors or adverse drug events in kidney transplant recipients...
  7. ncbi request reprint Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients
    David J Taber
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC 29425, USA
    Ann Pharmacother 41:944-50. 2007
    ..The use of protocols within other populations has been shown to improve recognition and treatment of common disease states, but outcome studies involving the use of protocols within transplant patients are lacking...
  8. doi request reprint No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies
    David J Taber
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC 29425, USA
    Surg Laparosc Endosc Percutan Tech 19:153-6. 2009
    ..48 mg/kg vs. 0.49+/-0.26 mg/kg vs. 0.53+/-0.36 mg/kg of total 4 morphine equivalents), or postoperative complications. Smoking status does not seem to impact perisurgical patient outcomes in patients undergoing laparoscopic nephrectomies...
  9. doi request reprint Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation
    D J Taber
    Medical University of South Carolina, Department of Pharmacy Services, Charleston, South Carolina 29425, USA
    Transplant Proc 40:3401-7. 2008
    ....
  10. doi request reprint Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation
    Emily B Hammond
    College of Medicine, Medical University of South Carolina, Charleston, SC, USA
    Clin Transplant 24:40-7. 2010
    ..African Americans (AA) have higher rejection rates and poorer graft outcomes compared to non-AAs. Induction therapy is yet unproven in this high risk population...
  11. ncbi request reprint Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, S C, USA
    Am J Nephrol 38:285-91. 2013
    ..There are no published studies assessing the safety and efficacy of thiazides as antihypertensives in kidney transplantation (KTX)...
  12. ncbi request reprint Prospective Randomized Controlled Trial of Rabbit Antithymocyte Globulin Compared With IL-2 Receptor Antagonist Induction Therapy in Kidney Transplantation
    Nicole A Pilch
    Department of Pharmacy Services, Division of Transplant Surgery, Division of Pathology and Laboratory Medicine, and Division of Nephrology, Medical University of South Carolina, Charleston, SC
    Ann Surg 259:888-93. 2014
    ....
  13. ncbi request reprint Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm
    Kenneth D Chavin
    Division of Transplantation, Department of Surgery, Medical University of South Carolina, Charleston, SC, USA
    Clin Transplant 27:732-41. 2013
    ..Using rigorous donor/recipient matching through a detailed algorithm, these data demonstrate that normal liver allograft outcomes are not superior to those in highly steatotic grafts. ..
  14. doi request reprint Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation
    John W McGillicuddy
    Medical University of South Carolina, Charleston, SC, USA
    Prog Transplant 23:33-8. 2013
    ..The increasing number of marginal deceased kidney donors and an aging recipient population, prolonged hospitalization, and increased costs have destabilized the economic viability of kidney transplants...
  15. doi request reprint Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients
    James N Fleming
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC 29425, USA
    Transpl Int 23:500-5. 2010
    ..14 and 0.94 respectively). Type of induction therapy does not appear to affect acute rejection rates or long-term graft survival in low-risk AA kidney transplant recipients...
  16. ncbi request reprint Long-term outcome of sirolimus rescue in kidney-pancreas transplantation
    Jeffrey Rogers
    Division of Transplant Surgery, Medical University of South Carolina, 96 Jonathan Lucas Street, CSB 404, Charleston, SC 29425, USA
    Transplantation 78:619-22. 2004
    ..All patients who were switched to SRL for TAC-induced hyperglycemia or MMF intolerance improved. Kidney-pancreas transplant recipients can be safely switched to SRL with excellent graft and patient survival...
  17. ncbi request reprint Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation
    Jenna L Scheffert
    1 Department of Pharmacy, New York Presbyterian Hospital, New York, NY 2 Department of Surgery, Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 3 Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC 4 Address correspondence to David J Taber, PharmD, Department of Surgery, Division of Transplant Surgery, Medical University of South Carolina, 96 Jonathan Lucas St, MSC 611 CSB 409, Charleston, SC 29425
    Transplantation 97:681-5. 2014
    ..Graft thrombosis following pancreas transplantation is the leading non-immunologic cause of graft loss. Routine systemic anticoagulation is controversial because of an increased bleeding risk...
  18. doi request reprint Graft outcomes in pediatric kidney transplantation: focus on the role of race
    Ibrahim F Shatat
    Pediatric Nephrology and Hypertension, MUSC Children s Hospital, Charleston, SC, USA
    Saudi J Kidney Dis Transpl 23:684-92. 2012
    ..In conclusion, our cohort showed several modifiable risk factors that can partially account for poorer graft survival in pediatric AA kidney transplant recipients...
  19. ncbi request reprint Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation
    Jeffrey Rogers
    Division of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    J Gastrointest Surg 7:1096-101. 2003
    ..There should therefore be a higher degree of suspicion for the presence of duodenojejunal anastomotic leaks in obese SPK recipients...
  20. doi request reprint Improving the perioperative value of care for vulnerable kidney transplant recipients
    David J Taber
    Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC 29425, USA
    J Am Coll Surg 216:668-76; discussion 676-8. 2013
    ..We engaged in a quality initiative in delayed graft function (DGF) kidney transplant recipients aimed at improving safe and efficient discharge...
  21. pmc Clinical and economic outcomes associated with medication errors in kidney transplantation
    David J Taber
    Division of Transplant Surgery, Department of Pharmacy Services, and, College of Nursing, Medical University of South Carolina, Charleston, South Carolina
    Clin J Am Soc Nephrol 9:960-6. 2014
    ..The objectives of this study were to determine the incidence and risk factors for MEs and ADRs and determine the association between transplant outcomes and these events...
  22. doi request reprint Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection
    Jill C Krisl
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA
    Clin J Am Soc Nephrol 7:1003-9. 2012
    ..This study aimed to determine if a pharmacodynamic relationship exists between BK viral load reduction and leflunomide metabolite, A77 1726, serum concentrations...
  23. doi request reprint Hypertension after kidney transplantation: a pathophysiologic approach
    Beje Thomas
    Division of Nephrology, Medical University of South Carolina, 96 Jonathan Lucas Street CSB 829, Charleston, SC, 29425, USA
    Curr Hypertens Rep 15:458-69. 2013
    ..Thus, there continues to be a need for larger studies examining the pathophysiology, diagnosis and treatment of hypertension in renal transplant recipients...
  24. doi request reprint Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients
    David J Taber
    Division of Transplant Surgery College of Medicine Department of Pharmacy Services and Division of Transplant Nephrology, Medical University of South Carolina, Charleston, South Carolina
    Ther Drug Monit 35:753-9. 2013
    ..The purpose of this study was to determine and compare the EVR PKs and concentration-associated efficacy and toxicity in African American and Caucasian adult kidney transplant recipients...
  25. ncbi request reprint Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk?
    John W McGillicuddy
    Department of Surgery, Medical University of South Carolina, Charleston, SC, USA
    Transplantation 89:1218-23. 2010
    ....
  26. doi request reprint Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies
    Brianne L Dunn
    Medical University of South Carolina, Charleston, SC 29425, USA
    Ann Pharmacother 44:1259-70. 2010
    ..To review the guidelines and literature for the treatment of hypertension in renal transplant patients and to provide guidance to practitioners in the selection of appropriate nonpharmacologic and pharmacologic treatment options...
  27. doi request reprint Generic immunosuppression: deciphering the message our patients are receiving
    Amanda L Hulbert
    Department of Pharmacy Services, The Ohio State University Medical Center, Columbus, OH, USA
    Ann Pharmacother 46:671-7. 2012
    ..A greater understanding of patient perceptions would enhance vital communication between providers and patients to facilitate education and appropriate monitoring...
  28. ncbi request reprint Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipients
    David J Taber
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, USA
    Ther Drug Monit 25:67-72. 2003
    ..Based on these results, the use of 24-hour urine CrCl to predict GFR and serum concentrations to properly dose vancomycin is advocated...
  29. ncbi request reprint Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation
    Douglas L Jennings
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 42:116-20. 2008
    ..To evaluate the safety and efficacy of early initiation of inhibitors of the renin-angiotensin-aldosterone system (RAAS) in renal transplant patients...
  30. ncbi request reprint Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?
    David J Taber
    School of Pharmacy, Wingate University, Wingate, NC, USA
    Transplantation 80:1633-5. 2005
    ..A larger, prospective analysis is warranted to compare these formulations of cyclosporine in de novo kidney transplant recipients...
  31. ncbi request reprint Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients
    David J Taber
    Department of Pharmacy, University of North Carolina School of Pharmacy and Medicine, Chapel Hill, NC 27599, USA
    Liver Transpl 8:219-23. 2002
    ..1% v 9.2%; P <.01). In conclusion, LRD recipients have significantly decreased tacrolimus dosing requirements compared with CAD recipients during the first 3 months posttransplantation despite having similar tacrolimus concentrations...